Survivors of childhood cancer face challenges from bone mineral density (BMD) deficits due to treatment exposures and other ...
When Anne Maldzinski underwent a blood stem-cell transplant to cure her cancer, the procedure triggered a life-threatening ...
The FDA has granted BTD to GSK’22, a B7-H3-targeted antibody-drug conjugate, for the treatment of adult patients with ...
Fred Hutch grew from a regional cancer center into a world-class biomedical research and clinical care institution known for ...
Childhood Cancer Society and Tour de Taverns worked with the Marco Island community to give a local girl with cancer a ...
Study finds dialysis patients taking denosumab have 36% higher risk for major cardiovascular events compared to those taking oral bisphosphonates.
Recruitment freezes in NHS scanning and cancer departments are risking patient care, the Royal College of Radiologists (RCR) ...
A Coralville mother is on a mission to raise awareness and funds for osteosarcoma research following the death of her ...
GSK plc (GSK, GSK.L) said that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation for GSK5764227, its ...
Linda Chavez, 34, was diagnosed with terminal lung cancer after years of ignoring symptoms like a persistent cough, bone pain ...
The FDA bestows a Breakthrough Therapy designation to GSK's antibody-drug conjugate, GSK5764227, for treating relapsed or refractory osteosarcoma.
A breakthrough in the study of bone cancer by scientists at the University of East Anglia could transform the way children with the disease ...